Ester Industries Limited has announced a comprehensive schedule for its Q3FY26 financial results disclosure, including both a board meeting and subsequent earnings call with investors and analysts. The company has formally notified stock exchanges about the upcoming board meeting on February 6, 2026, followed by an earnings call on February 9, 2026.

Board Meeting Details

The notification, dated February 2, 2026, was sent to both BSE Limited and National Stock Exchange of India Limited in compliance with regulatory requirements. The board meeting will focus on reviewing and approving the company's unaudited financial results for specific reporting periods.

Earnings Call Schedule

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ester Industries has scheduled an earnings call for investors and analysts to discuss the financial position for the quarter and nine months ended December 31, 2025.

International Access Numbers

The earnings call will accommodate global participation with dedicated access numbers for various regions.

Regulatory Compliance

The board meeting has been scheduled pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct, Ester Industries has implemented trading restrictions for its securities. The trading window will remain closed until 48 hours after the declaration of the financial results.

Corporate Communication

Both notifications were signed by Poornima Gupta, Company Secretary & Compliance Officer (Membership No: A49876), and digitally authenticated on February 2, 2026. The company maintains its corporate office in Gurgaon, Haryana, while its registered office and manufacturing works are located in Khatima, Udhampur, Jammu & Kashmir.

Ester Industries has granted 19,188 stock options to its Chief Marketing Officer under the company's Employee Stock Option Plan 2024, as announced through a regulatory filing on January 8, 2026. The grant was approved by the Nomination and Remuneration Committee through a resolution passed by circulation.

Stock Option Grant Details

The following table summarizes the key parameters of the stock option grant:

Pricing and Exercise Terms

The stock options have been priced at ₹79.00 per option, which represents a 20% discount to the fair market value. The fair market value was determined based on the closing price of ₹98.81 on January 7, 2026, on the National Stock Exchange of India Limited, where higher trading volumes were recorded.

Each option, upon exercise, will result in the issuance of one equity share of the company. The options carry a maximum exercise period of five years from the date of respective vesting, providing flexibility to the option holder.

ESOP 2024 Framework

The Employee Stock Option Plan 2024 is administered by the Nomination and Remuneration Committee and complies with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The scheme includes specific eligibility criteria for participation:

Eligible Participants

• Employees working exclusively in India or outside India
• Directors of the company (excluding independent directors)
• Employees of subsidiary or holding companies

Exclusions

• Promoters or promoter group members
• Directors holding more than 10% of outstanding equity shares

Vesting Requirements

The stock options will vest within a maximum period of five years from the date of grant, with specific vesting schedules to be outlined in individual grant letters. The plan mandates a minimum period of one year between the grant date and vesting of stock options, ensuring alignment with regulatory requirements.

The company has filed the requisite disclosures under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, maintaining transparency with stakeholders regarding this employee incentive initiative.